Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase
Articolo
Data di Pubblicazione:
2020
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Murillo Perez, Cf; Harms, Mh; Lindor, Kd; van Buuren, Hr; Hirschfield, Gm; Corpechot, C; van der Meer, Aj; Feld, Jj; Gulamhusein, A; Lammers, Wj; Ponsioen, Cy; Carbone, M; Mason, Al; Mayo, Mj; Invernizzi, P; Battezzati, Mp; Floreani, A; LLEO De Nalda, A; Nevens, F; Kowdley, Kv; Bruns, T; Dalekos, Gn; Gatselis, Nk; Thorburn, D; Trivedi, Pj; Verhelst, X; Parés, A; Janssen, Hla; Hansen BE– on behalf of the GLOBAL PBC Study, Group
Link alla scheda completa:
Pubblicato in: